ADVFN ADVFN

Hot Features

Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Regen Biopharma Inc (ID)

Regen Biopharma Inc (ID) (RGBPP)

0.0042
0.001
(31.25%)
終了 6月20日 5:00AM

Regen Biopharma Inc (ID) (RGBPP) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
0.0042
( 31.25% )
買値
0.0012
売値
0.50
出来高
2,447
0.0033 日の範囲 0.00495
0.00 52 週間の範囲 0.00
時価総額
前日終値
0.0032
始値
0.0033
最終取引時間
財務取引量
US$ 11
VWAP
0.00435
平均取引量 (3 か月)
US$ 18,117,430
発行済株式数
561,957,643
配当利回り
PER
-0.02
1 株当たり利益 (EPS)
-0.01
歳入
236.56k
純利益
-715.69k

Regen Biopharma Inc (ID) について

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to immune cell activation for oncology applications and immune cell suppression for autoimmune disease... Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to immune cell activation for oncology applications and immune cell suppression for autoimmune diseases. It also develops several products: HemaXellarate, a cellular therapeutic product derived from autologous stromal vascular fraction from adipose tissue; dCellVax, an autologous dendritic cell treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax, which is treated with siRNA to inhibit NR2F6, with the cells re-infused into the patient; DiffronC, which uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuraCAR, comprising CAR-T cells treated with an shRNA targeting the gene NR2F6. Regen BioPharma was incorporated in 2012 and is based in La Mesa, California. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
La Mesa, United States
設立
2026
Regen Biopharma Inc (ID) is listed in the Healthcare sector of the その他OTC with ticker RGBPP. The last closing price for Regen Biopharma (ID) was US$0. Over the last year, Regen Biopharma (ID) shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Regen Biopharma (ID) currently has 561,957,643 shares in issue. The market capitalisation of Regen Biopharma (ID) is US$2.36 million. Regen Biopharma (ID) has a price to earnings ratio (PE ratio) of -0.02.

RGBPP 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

RGBPP - Frequently Asked Questions (FAQ)

What is the current Regen Biopharma Inc (ID) share price?
The current share price of Regen Biopharma Inc (ID) is US$ 0.0042
How many Regen Biopharma Inc (ID) shares are in issue?
Regen Biopharma Inc (ID) has 561,957,643 shares in issue
What is the market cap of Regen Biopharma Inc (ID)?
The market capitalisation of Regen Biopharma Inc (ID) is USD 2.36M
What is the 1 year trading range for Regen Biopharma Inc (ID) share price?
Regen Biopharma Inc (ID) has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Regen Biopharma Inc (ID)?
The price to earnings ratio of Regen Biopharma Inc (ID) is -0.02
What is the cash to sales ratio of Regen Biopharma Inc (ID)?
The cash to sales ratio of Regen Biopharma Inc (ID) is 0.37
What is the registered address of Regen Biopharma Inc (ID)?
The registered address for Regen Biopharma Inc (ID) is 8697 La Mesa Boulevard, La Mesa, California, 91942
What is the Regen Biopharma Inc (ID) website address?
The website address for Regen Biopharma Inc (ID) is regenbiopharmainc.com
Which industry sector does Regen Biopharma Inc (ID) operate in?
Regen Biopharma Inc (ID) operates in the Biotechnology & Life Sciences sector

RGBPP 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

RGBPP Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock